Status:
COMPLETED
Lymphedema Prevention After Lymph Node Emptying
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Conditions:
Lymphedema
Breast Cancer
Eligibility:
FEMALE
18-85 years
Phase:
NA
Brief Summary
ABSTRACT Object: The impact of morbidity and the deterioration in health-related quality of life for patients with lymphedema after axillary lymph node dissection for breast cancer justify the impleme...
Detailed Description
This was a single-centre, open-label, controlled, randomized clinical trial. Patients were recruited from the Breast Pathology Unit at Hospital de la Santa Creu i Sant Pau (HSCSP), a tertiary referral...
Eligibility Criteria
Inclusion
- Having undergone a lymph node dissection as part of treatment for primary breast neoplasm
- Acceptance of the study conditions and signing of the informed consent
Exclusion
- Tumour recurrences
- Metastatic cancer
- Open wounds or loss of skin integrity
- Dependency or deterioration of higher functions
- Arterial insufficiency and deep vein thrombosis
- Acute heart failure
- Severe peripheral neuropathy
- Lymphedema
Key Trial Info
Start Date :
October 3 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 13 2015
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04785599
Start Date
October 3 2011
End Date
April 13 2015
Last Update
March 8 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.